adenosine diphosphate has been researched along with Hepatic Failure in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Amorim, JA; Castela, AC; Machado, IF; Palmeira, CM; Rolo, AP; Sinclair, DA; Steegborn, C; Teodoro, JS | 1 |
Chance, B; Hatano, E; Iwata, S; Kanazawa, A; Takahashi, R; Tanaka, A; Tsunekawa, S; Tsuyuki, S; Yamaoka, Y | 1 |
2 other study(ies) available for adenosine diphosphate and Hepatic Failure
Article | Year |
---|---|
The Soluble Adenylyl Cyclase Inhibitor LRE1 Prevents Hepatic Ischemia/Reperfusion Damage Through Improvement of Mitochondrial Function.
Topics: Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Constriction; Disease Models, Animal; Gene Expression Regulation; Hepatic Artery; Hormesis; Liver Failure; Male; Membrane Potential, Mitochondrial; Mitochondria, Liver; Oxygen Consumption; Phosphorylation; Portal Vein; Premedication; Pyrimidines; Random Allocation; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; Solubility; Thiophenes | 2020 |
Inhibition of tumor necrosis factor-induced apoptosis in transgenic mouse liver expressing creatine kinase.
Topics: Adenine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Caspase 3; Caspases; Creatine Kinase; DNA Fragmentation; Liver; Liver Failure; Membrane Potentials; Mice; Mice, Transgenic; Mitochondria; Tumor Necrosis Factor-alpha | 2004 |